Heller_2006_J.Child.Adolesc.Psychopharmacol_16_755

Reference

Title : Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study - Heller_2006_J.Child.Adolesc.Psychopharmacol_16_755
Author(s) : Heller JH , Spiridigliozzi GA , Crissman BG , Sullivan JA , Eells RL , Li JS , Doraiswamy PM , Krishnan KR , Kishnani PS
Ref : J Child Adolesc Psychopharmacol , 16 :755 , 2006
Abstract : Heller_2006_J.Child.Adolesc.Psychopharmacol_16_755
ESTHER : Heller_2006_J.Child.Adolesc.Psychopharmacol_16_755
PubMedSearch : Heller_2006_J.Child.Adolesc.Psychopharmacol_16_755
PubMedID: 17201619

Related information

Citations formats

Heller JH, Spiridigliozzi GA, Crissman BG, Sullivan JA, Eells RL, Li JS, Doraiswamy PM, Krishnan KR, Kishnani PS (2006)
Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study
J Child Adolesc Psychopharmacol 16 :755

Heller JH, Spiridigliozzi GA, Crissman BG, Sullivan JA, Eells RL, Li JS, Doraiswamy PM, Krishnan KR, Kishnani PS (2006)
J Child Adolesc Psychopharmacol 16 :755